文献速递临床免疫分子诊断

荧光微球免疫分析法检测裂谷热病毒核衣壳蛋白与糖蛋白抗体的评估

Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.
PubMed 文献 · J Clin Microbiol · 2018-05-25

该研究改进并评估了荧光微球免疫分析法(FMIA),用于同时检测针对裂谷热病毒(RVFV)糖蛋白Gn和核衣壳蛋白Np的IgG与IgM抗体。采用特征明确的疫苗接种和实验感染反刍动物血清,并与病毒中和试验平行比较。结果显示针对Np的IgG抗体 median荧光强度最高,Np与Gn靶标可区分感染动物与接种Gn/Gc亚单位疫苗的动物,表明FMIA是一种快速稳健的血清学诊断工具。

要点

  • FMIA可同时检测RVFV Np和Gn的IgG/IgM抗体,Np的IgG median荧光强度最高。
  • Np与Gn靶标能区分RVFV感染动物与接种Gn/Gc亚单位疫苗的动物。
  • FMIA与病毒中和试验平行使用,可作为快速稳健的血清学诊断工具。

核心结论

  • FMIA提供了一种快速且稳健的血清学诊断工具,用于检测针对裂谷热病毒的抗体。
  • 该 assay 的靶标为开发RVFV Gn/Gc亚单位疫苗的伴随诊断试验(DIVA)及多重血清学筛查奠定了基础。

研究设计与样本

  • 研究改进并评估了先前开发的荧光微球免疫分析法(FMIA),使用特征明确的疫苗接种和实验感染反刍动物血清。
  • 重组病毒蛋白偶联至聚苯乙烯磁珠,采用Luminex MAGPIX系统与xMAP技术分析,并与病毒中和试验平行进行。

主要发现

  • 针对RVFV Np的IgG抗体检测显示最高的median荧光强度(MFI)值,提示Np是筛查试验的良好候选抗原。
  • Np和Gn靶标能够区分感染动物与接种基于RVFV Gn和Gc蛋白的候选亚单位疫苗的动物。

临床怎么用

  • FMIA可用于反刍动物裂谷热病毒的血清学筛查和疫苗评估。
  • Np与Gn靶标组合可用于DIVA策略,区分自然感染与Gn/Gc亚单位疫苗接种动物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rift Valley fever virus (RVFV) is a mosquito-borne, zoonotic virus that infects ruminants, including cattle, sheep, goats, camels, and buffalo. Multiplexing diagnostic assays that can simultaneously detect antibodies against multiple RVFV antigens offer a high-throughput test for disease surveillance and vaccine evaluations. We describe the improvement and evaluation of a previously developed fluorescence microsphere immunoassay (FMIA) for the detection of IgG and IgM antibodies against the RVFV glycoprotein (Gn) and the immunogenic nucleocapsid protein (Np). Well-characterized vaccinated and experimentally infected ruminant sera were used for the evaluation of the assay. Recombinant viral proteins were produced and then coupled to polystyrene magnetic beads for analysis using the Luminex MAGPIX system with xMAP technology. The FMIA was performed in parallel with virus neutralization tests. Our results revealed the highest median fluorescence intensity (MFI) values for the detection of IgG antibodies against RVFV Np, indicating that this antigen would be a good candidate for a screening assay. The Np and Gn targets could differentiate infected animals from animals vaccinated with a candidate subunit vaccine formulation based on the RVFV Gn and Gc proteins. The results presented in this report demonstrate that FMIA provides a rapid and robust serological diagnostic tool for the detection of antibodies against RVFV. The targets developed in this assay provide the basis for the development of a companion diagnostic test for an RVFV Gn/Gc subunit vaccine that is capable of differentiating infected from vaccinated animals (DIVA), as well as a multiplex serodiagnostic assay that can simultaneously screen for several ruminant diseases.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Ragan IK, Davis AS, McVey DS, et al. Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins. J Clin Microbiol. 2018. PMID: 29563201. doi:10.1128/JCM.01626-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。